Lawrence J Saubermann, Mark Deneau, Richard A Falcone, Karen F Murray, Sabina Ali, Rohit Kohli, Udeme D Ekong, Pamela L Valentino, Andrew B Grossman, Elizabeth B Rand, Maureen M Jonas, Shehzad A Saeed, Binita M Kamath
Journal: Journal of pediatric gastroenterology and nutrition 2017;64(4):639-652
PMID: 27984347
Hepatobiliary disorders are common in patients with inflammatory bowel disease (IBD), and persistent abnormal liver function tests are found in approximately 20% to 30% of individuals with IBD. In most cases, the cause of these elevations will fall into 1 of 3 main categories. They can be as a result of extraintestinal manifestations of the disease process, related to medication toxicity, or the result of an underlying primary hepatic disorder unrelated to IBD. This latter possibility is beyond the scope of this review article, but does need to be considered in anyone with elevated liver function tests. This review is provided as a clinical summary of some of the major hepatic issues that may occur in patients with IBD.
Medical:
Other Literature Sources:
© Copyright 2026, Nutrition Evidence
We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.